Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2013, Article ID 819462, 8 pages
http://dx.doi.org/10.1155/2013/819462
Research Article

Synthesis of New Fluorine Substituted Heterocyclic Nitrogen Systems Derived from p-Aminosalicylic Acid as Antimycobacterial Agents

Department of Chemistry, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia

Received 23 March 2013; Accepted 29 May 2013

Academic Editor: Liviu Mitu

Copyright © 2013 Mohammed Saleh I. T. Makki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. H. Bacelar, M. A. Carvalho, and M. F. Proença, “Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of AntiMycobacterium tuberculosis agents,” European Journal of Medicinal Chemistry, vol. 45, no. 7, pp. 3234–3239, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Dye, “Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis,” Nature Reviews Microbiology, vol. 7, no. 1, pp. 81–87, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Ginsberg, “Emerging-drugs for active Tuberculosis,” Seminars in Respiratory and Critical Care Medicine, vol. 29, no. 5, pp. 552–559, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. H. D. H. Showalter and W. A. Denny, “A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment,” Tuberculosis, vol. 88, supplement 1, pp. S3–S17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Tomioka, Y. Tatano, K. Yasumoto, and T. Shimizu, “Recent advances in anti-tuberculous drug development and novel drug targets,” Expert Review of Respiratory Medicine, vol. 2, no. 4, pp. 455–471, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. R. C. Goldman, K. V. Plumley, and B. E. Laughon, “The evolution of extensively drug resistant tuberculosis (XDR-TB): history, status and issues for global control,” Infectious Disorders, vol. 7, no. 2, pp. 73–91, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Nguyen and C. J. Thompson, “Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm,” Trends in Microbiology, vol. 14, no. 7, pp. 304–312, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Prasad, S. K. Verma, S. Sahai, S. Kumar, and A. Jain, “Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients,” The Indian journal of Chest Diseases & Allied Sciences, vol. 48, no. 3, pp. 183–186, 2006. View at Google Scholar · View at Scopus
  9. B. Zhou, Y. He, X. Zhang et al., “Targeting mycobacterium protein tyrosine phosphatase B for antituberculosis agents,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 10, pp. 4573–4578, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Cremades, J. C. Rodríguez, E. García-Pachón et al., “Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model,” Journal of Antimicrobial Chemotherapy, vol. 66, no. 10, Article ID dkr281, pp. 2281–2283, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. B. E. Smart, “Fluorine substituent effects (on bioactivity)—a review,” Journal of Fluorine Chemistry, vol. 109, no. 1, pp. 3–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. H. G. Bonacorso, A. P. Wentz, R. V. Lourega et al., “Trifluoromethyl-containing pyrazolinyl (p-tolyl) sulfones: the synthesis and structure of promising antimicrobial agents,” Journal of Fluorine Chemistry, vol. 127, no. 8, pp. 1066–1072, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Olsen, D. W. Banner, P. Seiler et al., “Fluorine interactions at the thrombin active site: protein backbone fragments H-Cα-C=O comprise a favorable C-F environment and interactions of C-F with electrophiles,” ChemBioChem, vol. 5, no. 5, pp. 666–675, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. R. M. Abdel-Rahman, K. O. Al-Footy, and F. M. Aqlan, “Synthesis and antiinflammatory evaluation of some more new 1,2,4-triazolo[3,4-b] thiadiazoles as an antimicrobial agent—part-I,” International Journal of ChemTech Research, vol. 3, no. 1, pp. 423–434, 2011. View at Google Scholar · View at Scopus
  15. R. M. Abdel-Rahman, M. S. I. T. Makki, and W. A. Bawazir, “Synthesis of some more fluorine heterocyclic nitrogen systems derived from sulfa drugs as photochemical probe agents for inhibition of vitiligo disease-part i,” E-Journal of Chemistry, vol. 8, no. 1, pp. 405–414, 2011. View at Google Scholar · View at Scopus
  16. R. M. Abdel-Rahman, M. S. I. T. Makki, and W. A. B. Bawazir, “Synthesis of fluorine heterocyclic nitrogen systems derived from sulfa drugs as photochemical probe agents for inhibition of vitiligo disease—part II,” E-Journal of Chemistry, vol. 7, no. 1, pp. S93–S102, 2010. View at Google Scholar · View at Scopus
  17. T. E. Ali, R. M. Abdel-Rahman, F. I. Hanafy, and S. M. El-Edfawy, “Synthesis and molluscicidal activity of phosphorus-containing heterocyclic compounds derived from 5,6-bis (4-bromophenyl)-3-hydrazino-1,2,4-triazine,” Phosphorus, Sulfur and Silicon and the Related Elements, vol. 183, no. 10, pp. 2565–2577, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. R. M. Abdel-Rahman, “Chemistry of uncondensed 1,2,4-triazines, part iv synthesis and chemistry of bioactive 3-amino-1,2,4-triazines and related compounds—an overview,” Pharmazie, vol. 56, no. 4, pp. 275–286, 2001. View at Google Scholar · View at Scopus
  19. R. M. Abdel-Rahman, “Role of uncondensed 1,2,4-triazine compounds and related heterobicyclic systems as therapeutic agents—a review,” Pharmazie, vol. 56, no. 1, pp. 18–22, 2001. View at Google Scholar · View at Scopus
  20. R. M. Abdel-Rahman, “Role of uncondensed 1,2,4-triazine derivatives as biocidal plant protection agents—a review,” Pharmazie, vol. 56, no. 3, pp. 195–204, 2001. View at Google Scholar · View at Scopus
  21. L. A. Collins and S. G. Franzblau, “Microplate Alamar blue assay versus BACTEC 460 system for high- throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium,” Antimicrobial Agents and Chemotherapy, vol. 41, no. 5, pp. 1004–1009, 1997. View at Google Scholar · View at Scopus
  22. S. G. Küçükgüzel, S. Rollas, I. Küçükgüzel, and M. Kiraz, “Synthesis and antimycobacterial activity of some coupling products from 4-aminobenzoic acid hydrazones,” European Journal of Medicinal Chemistry, vol. 34, no. 12, pp. 1093–1100, 1999. View at Google Scholar
  23. R. M. Abdel-Rahman, “Chemoselective heterocyclization and pharmacological activities of new heterocycles—a review part v-synthesis of biocidal 4-thiazolidinones derivatives,” Bollettino Chimico Farmaceutico, vol. 140, no. 6, pp. 401–410, 2001. View at Google Scholar · View at Scopus
  24. M. S. I. T. Makki, R. M. Abdel-Rahman, H. M. Faidallah, and K. A. Khan, “Synthesis of substituted thioureas and their sulfur heterocyclic systems of p-amino salicylic acid as antimycobacterial agents,” Journal of Chemistry, vol. 2013, Article ID 862463, 9 pages, 2013. View at Publisher · View at Google Scholar